APO Research
Talk to an analyst

APO RESEARCH · REPORT

PVA Foam Embolization Particles

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global PVA Foam Embolization Particles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025186 pages

Choose your research edition.

Industry ResearchPVA Foam Embolization Particles Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal PVA Foam Embolization Particles Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal PVA Foam Embolization Particles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PVA Foam Embolization Particles Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal PVA Foam Embolization Particles Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PVA Foam Embolization Particles market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PVA Foam Embolization Particles include Terumo, Sirtex Medical, Merit Medical, INterface BIOmaterials, HENGRUI Medical, Cook Medical, BTG Medical, Boston Scientific and Alicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PVA Foam Embolization Particles market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PVA Foam Embolization Particles and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PVA Foam Embolization Particles sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PVA Foam Embolization Particles market size, projected growth trends, production technologies, key applications, and end-use industries.

PVA Foam Embolization Particles Segment by Company

Terumo

Sirtex Medical

Merit Medical

INterface BIOmaterials

HENGRUI Medical

Cook Medical

BTG Medical

Boston Scientific

Alicon

PVA Foam Embolization Particles Segment by Type

50μm～350μm

350μm～560μm

560μm～710μm

710μm～1000μm

1000μm～1400μm

1400μm～2000μm

PVA Foam Embolization Particles Segment by Application

Trauma Embolization

Liver Tumor Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Uterine Fibroid Embolization

Others

PVA Foam Embolization Particles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PVA Foam Embolization Particles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PVA Foam Embolization Particles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PVA Foam Embolization Particles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PVA Foam Embolization Particles market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PVA Foam Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of PVA Foam Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of PVA Foam Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. PVA Foam Embolization Particles Industry Trends Table 2. PVA Foam Embolization Particles Industry Drivers Table 3. PVA Foam Embolization Particles Industry Opportunities and Challenges Table 4. PVA Foam Embolization Particles Industry Restraints Table 5. Global PVA Foam Embolization Particles Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global PVA Foam Embolization Particles Revenue Market Share by Manufacturers (2021-2026) Table 7. Global PVA Foam Embolization Particles Sales by Manufacturers (k units) & (2021-2026) Table 8. Global PVA Foam Embolization Particles Sales Market Share by Manufacturers Table 9. Global PVA Foam Embolization Particles Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global PVA Foam Embolization Particles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global PVA Foam Embolization Particles Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global PVA Foam Embolization Particles Manufacturers, Product Type & Application Table 13. Global PVA Foam Embolization Particles Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global PVA Foam Embolization Particles by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50μm～350μm Table 17. Major Manufacturers of 350μm～560μm Table 18. Major Manufacturers of 560μm～710μm Table 19. Major Manufacturers of 710μm～1000μm Table 20. Major Manufacturers of 1000μm～1400μm Table 21. Major Manufacturers of 1400μm～2000μm Table 22. Global PVA Foam Embolization Particles Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 24. Global PVA Foam Embolization Particles Sales by Type (2027-2032) & (k units) Table 25. Global PVA Foam Embolization Particles Sales Market Share by Type (2021-2026) Table 26. Global PVA Foam Embolization Particles Sales Market Share by Type (2027-2032) Table 27. Global PVA Foam Embolization Particles Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global PVA Foam Embolization Particles Revenue by Type (2021-2026) & (k units) Table 29. Global PVA Foam Embolization Particles Revenue by Type (2027-2032) & (k units) Table 30. Global PVA Foam Embolization Particles Revenue Market Share by Type (2021-2026) Table 31. Global PVA Foam Embolization Particles Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Trauma Embolization Table 33. Major Manufacturers of Liver Tumor Embolization Table 34. Major Manufacturers of Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Table 35. Major Manufacturers of Uterine Fibroid Embolization Table 36. Major Manufacturers of Others Table 37. Global PVA Foam Embolization Particles Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 39. Global PVA Foam Embolization Particles Sales by Application (2027-2032) & (k units) Table 40. Global PVA Foam Embolization Particles Sales Market Share by Application (2021-2026) Table 41. Global PVA Foam Embolization Particles Sales Market Share by Application (2027-2032) Table 42. Global PVA Foam Embolization Particles Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global PVA Foam Embolization Particles Revenue by Application (2021-2026) & (k units) Table 44. Global PVA Foam Embolization Particles Revenue by Application (2027-2032) & (k units) Table 45. Global PVA Foam Embolization Particles Revenue Market Share by Application (2021-2026) Table 46. Global PVA Foam Embolization Particles Revenue Market Share by Application (2027-2032) Table 47. Global PVA Foam Embolization Particles Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global PVA Foam Embolization Particles Sales by Region (2021-2026) & (k units) Table 49. Global PVA Foam Embolization Particles Sales Market Share by Region (2021-2026) Table 50. Global PVA Foam Embolization Particles Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global PVA Foam Embolization Particles Sales Forecasted Market Share by Region (2027-2032) Table 52. North America PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 54. North America PVA Foam Embolization Particles Sales by Country (2027-2032) & (k units) Table 55. Europe PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 57. Europe PVA Foam Embolization Particles Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific PVA Foam Embolization Particles Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa PVA Foam Embolization Particles Sales by Country (2027-2032) & (k units) Table 64. Global PVA Foam Embolization Particles Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global PVA Foam Embolization Particles Revenue by Region (2021-2026) & (US$ Million) Table 66. Global PVA Foam Embolization Particles Revenue by Region (2027-2032) & (US$ Million) Table 67. Global PVA Foam Embolization Particles Revenue Market Share by Region (2021-2026) Table 68. Global PVA Foam Embolization Particles Revenue Market Share by Region (2027-2032) Table 69. Terumo Company Information Table 70. Terumo Business Overview Table 71. Terumo PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Terumo PVA Foam Embolization Particles Product Portfolio Table 73. Terumo Recent Development Table 74. Sirtex Medical Company Information Table 75. Sirtex Medical Business Overview Table 76. Sirtex Medical PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sirtex Medical PVA Foam Embolization Particles Product Portfolio Table 78. Sirtex Medical Recent Development Table 79. Merit Medical Company Information Table 80. Merit Medical Business Overview Table 81. Merit Medical PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Merit Medical PVA Foam Embolization Particles Product Portfolio Table 83. Merit Medical Recent Development Table 84. INterface BIOmaterials Company Information Table 85. INterface BIOmaterials Business Overview Table 86. INterface BIOmaterials PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. INterface BIOmaterials PVA Foam Embolization Particles Product Portfolio Table 88. INterface BIOmaterials Recent Development Table 89. HENGRUI Medical Company Information Table 90. HENGRUI Medical Business Overview Table 91. HENGRUI Medical PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. HENGRUI Medical PVA Foam Embolization Particles Product Portfolio Table 93. HENGRUI Medical Recent Development Table 94. Cook Medical Company Information Table 95. Cook Medical Business Overview Table 96. Cook Medical PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Cook Medical PVA Foam Embolization Particles Product Portfolio Table 98. Cook Medical Recent Development Table 99. BTG Medical Company Information Table 100. BTG Medical Business Overview Table 101. BTG Medical PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. BTG Medical PVA Foam Embolization Particles Product Portfolio Table 103. BTG Medical Recent Development Table 104. Boston Scientific Company Information Table 105. Boston Scientific Business Overview Table 106. Boston Scientific PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Boston Scientific PVA Foam Embolization Particles Product Portfolio Table 108. Boston Scientific Recent Development Table 109. Alicon Company Information Table 110. Alicon Business Overview Table 111. Alicon PVA Foam Embolization Particles Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Alicon PVA Foam Embolization Particles Product Portfolio Table 113. Alicon Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. PVA Foam Embolization Particles Distributors List Table 117. PVA Foam Embolization Particles Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. PVA Foam Embolization Particles Product Image Figure 2. Global PVA Foam Embolization Particles Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PVA Foam Embolization Particles Market Size (2021-2032) & (US$ Million) Figure 4. Global PVA Foam Embolization Particles Sales (2021-2032) & (k units) Figure 5. Global PVA Foam Embolization Particles Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 PVA Foam Embolization Particles Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50μm～350μm Image Figure 9. 350μm～560μm Image Figure 10. 560μm～710μm Image Figure 11. 710μm～1000μm Image Figure 12. 1000μm～1400μm Image Figure 13. 1400μm～2000μm Image Figure 14. Global PVA Foam Embolization Particles Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global PVA Foam Embolization Particles Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global PVA Foam Embolization Particles Sales Market Share by Type (2021-2032) Figure 17. Global PVA Foam Embolization Particles Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global PVA Foam Embolization Particles Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global PVA Foam Embolization Particles Revenue Market Share by Type (2021-2032) Figure 20. Trauma Embolization Image Figure 21. Liver Tumor Embolization Image Figure 22. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Image Figure 23. Uterine Fibroid Embolization Image Figure 24. Others Image Figure 25. Global PVA Foam Embolization Particles Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global PVA Foam Embolization Particles Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global PVA Foam Embolization Particles Sales Market Share by Application (2021-2032) Figure 28. Global PVA Foam Embolization Particles Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global PVA Foam Embolization Particles Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global PVA Foam Embolization Particles Revenue Market Share by Application (2021-2032) Figure 31. North America PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America PVA Foam Embolization Particles Sales Market Share by Country (2021-2032) Figure 33. U.S. PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe PVA Foam Embolization Particles Sales Market Share by Country (2021-2032) Figure 38. Germany PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 39. France PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Country (2021-2032) Figure 45. China PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 49. India PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country (2021-2032) Figure 53. Brazil PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile PVA Foam Embolization Particles Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global PVA Foam Embolization Particles Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global PVA Foam Embolization Particles Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America PVA Foam Embolization Particles Revenue (2021-2032) & (US$ Million) Figure 64. North America PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe PVA Foam Embolization Particles Revenue (2021-2032) & (US$ Million) Figure 66. Europe PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific PVA Foam Embolization Particles Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa PVA Foam Embolization Particles Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. PVA Foam Embolization Particles Value Chain Figure 72. Manufacturing Cost Structure Figure 73. PVA Foam Embolization Particles Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 50μm～350μm
  • 350μm～560μm
  • 560μm～710μm
  • 710μm～1000μm
  • 1000μm～1400μm
  • 1400μm～2000μm
Applications
  • Trauma Embolization
  • Liver Tumor Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Uterine Fibroid Embolization
  • Others
Companies covered
  • Terumo
  • Sirtex Medical
  • Merit Medical
  • INterface BIOmaterials
  • HENGRUI Medical
  • Cook Medical
  • BTG Medical
  • Boston Scientific
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PVA Foam Embolization Particles Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PVA Foam Embolization Particles Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global PVA Foam Embolization Particles Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global PVA Foam Embolization Particles Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global PVA Foam Embolization Particles Market Dynamics
  1. 2.1 PVA Foam Embolization Particles Industry Trends
  2. 2.2 PVA Foam Embolization Particles Industry Drivers
  3. 2.3 PVA Foam Embolization Particles Industry Opportunities and Challenges
  4. 2.4 PVA Foam Embolization Particles Industry Restraints
3 PVA Foam Embolization Particles Market by Manufacturers
  1. 3.1 Global PVA Foam Embolization Particles Revenue by Manufacturers (2021-2026)
  2. 3.2 Global PVA Foam Embolization Particles Sales by Manufacturers (2021-2026)
  3. 3.3 Global PVA Foam Embolization Particles Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global PVA Foam Embolization Particles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PVA Foam Embolization Particles Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global PVA Foam Embolization Particles Manufacturers, Product Type & Application
  7. 3.7 Global PVA Foam Embolization Particles Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PVA Foam Embolization Particles Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PVA Foam Embolization Particles Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PVA Foam Embolization Particles Tier 1, Tier 2, and Tier 3
4 PVA Foam Embolization Particles Market by Type
  1. 4.1 PVA Foam Embolization Particles Type Introduction
  2. 4.1.1 50μm～350μm
  3. 4.1.2 350μm～560μm
  4. 4.1.3 560μm～710μm
  5. 4.1.4 710μm～1000μm
  6. 4.1.5 1000μm～1400μm
  7. 4.1.6 1400μm～2000μm
  8. 4.2 Global PVA Foam Embolization Particles Sales by Type
  9. 4.2.1 Global PVA Foam Embolization Particles Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global PVA Foam Embolization Particles Sales by Type (2021-2032)
  11. 4.2.3 Global PVA Foam Embolization Particles Sales Market Share by Type (2021-2032)
  12. 4.3 Global PVA Foam Embolization Particles Revenue by Type
  13. 4.3.1 Global PVA Foam Embolization Particles Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global PVA Foam Embolization Particles Revenue by Type (2021-2032)
  15. 4.3.3 Global PVA Foam Embolization Particles Revenue Market Share by Type (2021-2032)
5 PVA Foam Embolization Particles Market by Application
  1. 5.1 PVA Foam Embolization Particles Application Introduction
  2. 5.1.1 Trauma Embolization
  3. 5.1.2 Liver Tumor Embolization
  4. 5.1.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  5. 5.1.4 Uterine Fibroid Embolization
  6. 5.1.5 Others
  7. 5.2 Global PVA Foam Embolization Particles Sales by Application
  8. 5.2.1 Global PVA Foam Embolization Particles Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global PVA Foam Embolization Particles Sales by Application (2021-2032)
  10. 5.2.3 Global PVA Foam Embolization Particles Sales Market Share by Application (2021-2032)
  11. 5.3 Global PVA Foam Embolization Particles Revenue by Application
  12. 5.3.1 Global PVA Foam Embolization Particles Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global PVA Foam Embolization Particles Revenue by Application (2021-2032)
  14. 5.3.3 Global PVA Foam Embolization Particles Revenue Market Share by Application (2021-2032)
6 Global PVA Foam Embolization Particles Sales by Region
  1. 6.1 Global PVA Foam Embolization Particles Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PVA Foam Embolization Particles Sales by Region (2021-2032)
  3. 6.2.1 Global PVA Foam Embolization Particles Sales by Region (2021-2026)
  4. 6.2.2 Global PVA Foam Embolization Particles Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America PVA Foam Embolization Particles Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe PVA Foam Embolization Particles Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific PVA Foam Embolization Particles Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa PVA Foam Embolization Particles Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global PVA Foam Embolization Particles Revenue by Region
  1. 7.1 Global PVA Foam Embolization Particles Revenue by Region
  2. 7.1.1 Global PVA Foam Embolization Particles Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global PVA Foam Embolization Particles Revenue by Region (2021-2026)
  4. 7.1.3 Global PVA Foam Embolization Particles Revenue by Region (2027-2032)
  5. 7.1.4 Global PVA Foam Embolization Particles Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America PVA Foam Embolization Particles Revenue (2021-2032)
  8. 7.2.2 North America PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe PVA Foam Embolization Particles Revenue (2021-2032)
  11. 7.3.2 Europe PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific PVA Foam Embolization Particles Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa PVA Foam Embolization Particles Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa PVA Foam Embolization Particles Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Terumo
  2. 8.1.1 Terumo Company Information
  3. 8.1.2 Terumo Business Overview
  4. 8.1.3 Terumo PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Terumo PVA Foam Embolization Particles Product Portfolio
  6. 8.1.5 Terumo Recent Developments
  7. 8.2 Sirtex Medical
  8. 8.2.1 Sirtex Medical Company Information
  9. 8.2.2 Sirtex Medical Business Overview
  10. 8.2.3 Sirtex Medical PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sirtex Medical PVA Foam Embolization Particles Product Portfolio
  12. 8.2.5 Sirtex Medical Recent Developments
  13. 8.3 Merit Medical
  14. 8.3.1 Merit Medical Company Information
  15. 8.3.2 Merit Medical Business Overview
  16. 8.3.3 Merit Medical PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merit Medical PVA Foam Embolization Particles Product Portfolio
  18. 8.3.5 Merit Medical Recent Developments
  19. 8.4 INterface BIOmaterials
  20. 8.4.1 INterface BIOmaterials Company Information
  21. 8.4.2 INterface BIOmaterials Business Overview
  22. 8.4.3 INterface BIOmaterials PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 INterface BIOmaterials PVA Foam Embolization Particles Product Portfolio
  24. 8.4.5 INterface BIOmaterials Recent Developments
  25. 8.5 HENGRUI Medical
  26. 8.5.1 HENGRUI Medical Company Information
  27. 8.5.2 HENGRUI Medical Business Overview
  28. 8.5.3 HENGRUI Medical PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HENGRUI Medical PVA Foam Embolization Particles Product Portfolio
  30. 8.5.5 HENGRUI Medical Recent Developments
  31. 8.6 Cook Medical
  32. 8.6.1 Cook Medical Company Information
  33. 8.6.2 Cook Medical Business Overview
  34. 8.6.3 Cook Medical PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cook Medical PVA Foam Embolization Particles Product Portfolio
  36. 8.6.5 Cook Medical Recent Developments
  37. 8.7 BTG Medical
  38. 8.7.1 BTG Medical Company Information
  39. 8.7.2 BTG Medical Business Overview
  40. 8.7.3 BTG Medical PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BTG Medical PVA Foam Embolization Particles Product Portfolio
  42. 8.7.5 BTG Medical Recent Developments
  43. 8.8 Boston Scientific
  44. 8.8.1 Boston Scientific Company Information
  45. 8.8.2 Boston Scientific Business Overview
  46. 8.8.3 Boston Scientific PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Scientific PVA Foam Embolization Particles Product Portfolio
  48. 8.8.5 Boston Scientific Recent Developments
  49. 8.9 Alicon
  50. 8.9.1 Alicon Company Information
  51. 8.9.2 Alicon Business Overview
  52. 8.9.3 Alicon PVA Foam Embolization Particles Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alicon PVA Foam Embolization Particles Product Portfolio
  54. 8.9.5 Alicon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PVA Foam Embolization Particles Value Chain Analysis
  2. 9.1.1 PVA Foam Embolization Particles Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PVA Foam Embolization Particles Production Mode & Process
  6. 9.2 PVA Foam Embolization Particles Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PVA Foam Embolization Particles Distributors
  9. 9.2.3 PVA Foam Embolization Particles Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst